This is great news for people withatrial fibrillation (AF)who take the newer anticoagulantsEliquisorXarelto. According to arecent article in Cardiology Newsthe FDA, in early May 2018, approved Andexxa (Portola Pharmaceuticals), the first reversal agent for the popular newer anticoagulants Eliquis and...